These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 25994122

  • 1. Antithymocyte globulin dosing effects on biopsy-proven acute rejection and infection risk.
    Tenney JW, Mokaddem S, Shah V, Adekile A.
    Ann Transplant; 2015 May 21; 20():285-9. PubMed ID: 25994122
    [Abstract] [Full Text] [Related]

  • 2. Comparison of clinical outcome of low-dose and high-dose rabbit antithymocyte globulin induction therapy in renal transplantation: a single-center experience.
    Yang JW, Wang JN, Men TY, Zhang XM, Li XD, Shen B, Li GY, Chen DD.
    Ann Transplant; 2014 Jun 06; 19():277-82. PubMed ID: 24906405
    [Abstract] [Full Text] [Related]

  • 3. Renal transplantation in the setting of early steroid withdrawal: a comparison of rabbit antithymocyte globulin induction dosing in two eras.
    Rogers CC, Asipenko N, Horwedel T, Gautam S, Goldfarb-Rumyantzev AS, Pavlakis M, Johnson SR, Karp SJ, Evenson A, Khwaja K, Hanto DW, Mandelbrot DA.
    Am J Nephrol; 2013 Jun 06; 38(5):397-404. PubMed ID: 24192457
    [Abstract] [Full Text] [Related]

  • 4. Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal.
    Saull HE, Enderby CY, Gonwa TA, Wadei HM.
    Clin Transplant; 2015 Jul 06; 29(7):573-80. PubMed ID: 25711849
    [Abstract] [Full Text] [Related]

  • 5. Impact of small variations in the delivered dose of rabbit antithymocyte induction therapy in kidney transplantation with early corticosteroid withdrawal.
    Tsapepas DS, Mohan S, Tanriover B, Dube G, Crew RJ, Cohen DJ, Hardy MA, Sandoval PR, Ratner LE.
    Transplantation; 2012 Aug 27; 94(4):325-30. PubMed ID: 22814328
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomes.
    Trofe-Clark J, Reese PP, Patel HJ, Jakobowski D, Goral S, Doll SL, Abt PL, Bloom RD.
    Transplantation; 2012 Sep 15; 94(5):506-12. PubMed ID: 22895613
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients.
    Pennington CA, Tischer SM, Lee E, Lee S, Sindelar J, Park JM.
    Pharmacotherapy; 2015 Aug 15; 35(8):748-54. PubMed ID: 26234282
    [Abstract] [Full Text] [Related]

  • 8. Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection.
    Deeks ED, Keating GM.
    Drugs; 2009 Jul 30; 69(11):1483-512. PubMed ID: 19634926
    [Abstract] [Full Text] [Related]

  • 9. 5-year results of a prospective, randomized, single-center study of alemtuzumab compared with rabbit antithymocyte globulin induction in simultaneous kidney-pancreas transplantation.
    Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Farney AC.
    Transplant Proc; 2014 Jul 30; 46(6):1928-31. PubMed ID: 25131073
    [Abstract] [Full Text] [Related]

  • 10. Effects of Ideal Versus Total Body Weight Dosage of Rabbit Antithymocyte Globulin on Outcomes of Kidney Transplant Patients With High Immunologic Risk.
    Vacha M, Gommer J, Rege A, Sanoff S, Sudan D, Harris M.
    Exp Clin Transplant; 2016 Oct 30; 14(5):511-517. PubMed ID: 26742693
    [Abstract] [Full Text] [Related]

  • 11. Impact of Rabbit Antithymocyte Globulin Dose on Long-term Outcomes in Heart Transplant Patients.
    Aliabadi AZ, Grömmer M, Dunkler D, Eskandary F, Salameh O, Gökler J, Hutschala D, Steinlechner B, Opfermann P, Laufer G, Zuckermann AO.
    Transplantation; 2016 Mar 30; 100(3):685-93. PubMed ID: 26457604
    [Abstract] [Full Text] [Related]

  • 12. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients.
    Klem P, Cooper JE, Weiss AS, Gralla J, Owen P, Chan L, Wiseman AC.
    Transplantation; 2009 Oct 15; 88(7):891-6. PubMed ID: 19935460
    [Abstract] [Full Text] [Related]

  • 13. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
    Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ.
    Transplantation; 2009 Sep 27; 88(6):810-9. PubMed ID: 19920781
    [Abstract] [Full Text] [Related]

  • 14. Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age.
    Patel SJ, Knight RJ, Suki WN, Abdellatif A, Duhart BT, Krauss AG, Mannan S, Nezakatgoo N, Osama Gaber A.
    Clin Transplant; 2011 Sep 27; 25(3):E250-6. PubMed ID: 21231963
    [Abstract] [Full Text] [Related]

  • 15. Randomized trial of rATg/Daclizumab vs. rATg/Alemtuzumab as dual induction therapy in renal transplantation: Results at 8years of follow-up.
    Ciancio G, Gaynor JJ, Guerra G, Sageshima J, Roth D, Chen L, Kupin W, Mattiazzi A, Tueros L, Flores S, Hanson L, Ruiz P, Vianna R, Burke GW.
    Transpl Immunol; 2017 Feb 27; 40():42-50. PubMed ID: 27888093
    [Abstract] [Full Text] [Related]

  • 16. Low Immunologic Risk Living Related Renal Transplant Using Very Low-Dose Antithymocyte Globulin as Induction Therapy: A Single Tertiary Hospital Experience.
    Jalalonmuhali M, Ng KP, Ong CS, Lee YW, Wan Md Adnan WAH, Lim SK.
    Transplant Proc; 2020 Feb 27; 52(6):1709-1714. PubMed ID: 32448669
    [Abstract] [Full Text] [Related]

  • 17. Rabbit antithymocyte globulin induction therapy in adult renal transplantation.
    Hardinger KL.
    Pharmacotherapy; 2006 Dec 27; 26(12):1771-83. PubMed ID: 17125438
    [Abstract] [Full Text] [Related]

  • 18. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients.
    Khanmoradi K, Knorr JP, Feyssa EL, Parsikia A, Jawa P, Dinh DB, Campos S, Zaki RF, Ortiz JA.
    Exp Clin Transplant; 2013 Jun 27; 11(3):222-8. PubMed ID: 23432665
    [Abstract] [Full Text] [Related]

  • 19. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report.
    Stevens RB, Mercer DF, Grant WJ, Freifeld AG, Lane JT, Groggel GC, Rigley TH, Nielsen KJ, Henning ME, Skorupa JY, Skorupa AJ, Christensen KA, Sandoz JP, Kellogg AM, Langnas AN, Wrenshall LE.
    Transplantation; 2008 May 27; 85(10):1391-9. PubMed ID: 18497677
    [Abstract] [Full Text] [Related]

  • 20. The influence of the antithymocyte globulin dose on clinical outcomes of patients undergoing kidney retransplantation.
    Linhares K, Taddeo JB, Cristelli MP, Proença H, Ficher KN, de Marco R, Gerbase-DeLima M, Medina-Pestana J, Tedesco-Silva H.
    PLoS One; 2021 May 27; 16(5):e0251384. PubMed ID: 33979389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.